Assertio Holdings, Inc. (ASRT)
23.32
0.00 (0.00%)
USD |
NASDAQ |
May 15, 16:00
23.32
0.00 (0.00%)
After-Hours: 20:00
Assertio Holdings Research and Development Expense (Quarterly) : 0.454M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 10.60M |
| Corcept Therapeutics, Inc. | 66.26M |
| Merck & Co., Inc. | 11.98B |
| Lipocine, Inc. | 2.750M |
| Theravance Biopharma, Inc. | 5.448M |